Our findings underscore the application of CRISPR‐Cas9 in human iPSC‐derived organoid models to investigate APOE genotype‐specific effects on tau pathology using SERS, suggesting a robust platform for advancing AD research. Here, MAPT is linked to Alzheimer disease.